Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124227872 | 12422787 | 2 | F | 20120530 | 20160722 | 20160601 | 20160908 | PER | US-ASTRAZENECA-2014SE23593 | ASTRAZENECA | 24532.00 | DY | M | Y | 89.40000 | KG | 20160909 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124227872 | 12422787 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 210 | MG | 22200 | 2 | MG | /wk | ||||||
| 124227872 | 12422787 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 0 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 124227872 | 12422787 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 0 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QD | |||||
| 124227872 | 12422787 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 0 | 5 | MG | BID | ||||||||
| 124227872 | 12422787 | 5 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 124227872 | 12422787 | 6 | C | LINAGLIPTIN/METFORMIN HYDROCHLORIDE | 2 | Oral | 0 | 5 | MG | QD | |||||||||
| 124227872 | 12422787 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 124227872 | 12422787 | 8 | C | INSULIN | INSULIN NOS | 1 | Subcutaneous | 0 | 1 | DF | QD | ||||||||
| 124227872 | 12422787 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 124227872 | 12422787 | 10 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 124227872 | 12422787 | 11 | C | FOLBEE | CYANOCOBALAMINFOLIC ACIDPYRIDOXINE HYDROCHLORIDE | 1 | DAILY | 0 | |||||||||||
| 124227872 | 12422787 | 12 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | IU | QD | ||||||||
| 124227872 | 12422787 | 13 | C | TYLENOL SUBSTITUTE | 2 | Oral | 0 | 2 | DF | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124227872 | 12422787 | 1 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 2 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 3 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 4 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 5 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 6 | Type 2 diabetes mellitus |
| 124227872 | 12422787 | 9 | Hypertension |
| 124227872 | 12422787 | 10 | Hypertension |
| 124227872 | 12422787 | 11 | Hypovitaminosis |
| 124227872 | 12422787 | 12 | Vitamin D deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124227872 | 12422787 | Blood glucose increased | |
| 124227872 | 12422787 | Fatigue | |
| 124227872 | 12422787 | Hypersomnia | |
| 124227872 | 12422787 | Intentional product misuse | |
| 124227872 | 12422787 | Product packaging quantity issue | |
| 124227872 | 12422787 | Product quality issue | |
| 124227872 | 12422787 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124227872 | 12422787 | 1 | 20120530 | 0 | ||
| 124227872 | 12422787 | 2 | 201202 | 20160410 | 0 | |
| 124227872 | 12422787 | 3 | 201402 | 0 | ||
| 124227872 | 12422787 | 5 | 20120529 | 0 | ||
| 124227872 | 12422787 | 6 | 20120529 | 0 | ||
| 124227872 | 12422787 | 8 | 2014 | 0 | ||
| 124227872 | 12422787 | 9 | 2011 | 0 | ||
| 124227872 | 12422787 | 10 | 2011 | 0 | ||
| 124227872 | 12422787 | 11 | 2011 | 0 | ||
| 124227872 | 12422787 | 12 | 2014 | 0 | ||
| 124227872 | 12422787 | 13 | 2015 | 0 |